Postoperative clinical outcomes of patients with thymic epithelial tumors after over-3-year follow-up at a single-center

Table 5 Analysis of influencing factors for achieving CSR in thymoma patients with MG

Variables	Univariate model			Multivariate model
Variables	OR	95% CI	P value	OR	95% CI	P value
Sex
Female	Reference
Male	1.006	0.541–1.870	0.985
Age	0.977	0.954–1.000	0.051	0.978	0.953–1.004	0.092
Preoperative course
< 12 month	Reference
≥ 12 month	0.350	0.108–1.137	0.081	0.413	0.126–1.352	0.144
Application of hormone	0.863	0.266–2.799	0.806
Application of immunosuppressants	0.272	0.037–1.984	0.199
Osserman classification
I	Reference
IIA + IIB + III + IV	0.526	0.267–1.036	0.063	0.481	0.242–0.956	0.037
WHO pathological classification
A + AB + MNT	Reference
B + MIX	1.492	0.531–4.194	0.448
Masaoka-Koga staging
I + II	Reference
III + IV	0.746	0.355–1.566	0.438
TNM staging
I + II	Reference
III + IV	0.683	0.302–1.545	0.360
Surgical approach
OT	Reference
VATS	0.534	0.2877–0.995	0.048	0.610	0.321–1.157	0.130
Resection status
R0	Reference
None R0	0.785	0.189–3.256	0.739
Perioperative complications	1.010	0.445–2.289	0.982
Postoperative therapy	1.232	0.626–2.424	0.546

ISSN: 1749-8090